WSFx Global Pay Regulatory Approval

Earnings Call

WSFx Global Pay Earnings Call Transcript: Key Takeaways

WSFx delivered record Q2 turnover growth led by student remittances, despite macro headwinds in the US market. The pivot toward high-volume B2B channels is driving scale but compressing margins due to higher commission payouts.

Earnings Call

WSFx Global Pay Investor Presentation: Key Takeaways

Q2 FY27 revenue from operations ₹44.58 Cr (+30.0% YoY), PBT ₹5.33 Cr (+9.6%), gross turnover ₹2,914 Cr (+41.2%). Perpetual AD-II licence received 30 July 2026.

Employee Stock Options

WSFx Global Pay Employee Stock Options

WSFx Global Pay allotted 1,62,500 ESOPs to eligible employees under its 2018 scheme, effective 27 October 2026. Options vest in tranches through October 2029.

Capacity Expansion

WSFx Global Pay Capacity Expansion

WSFx Global Pay's board approved opening a new branch office in Kanpur, Uttar Pradesh, expected on or before December 15, 2026. The branch is part of the company's regional business expansion.

new branches

1.0 branches

Financial Results

WSFx Global Pay Q2 FY27 Results: Net Profit ₹4.3 Cr, Up 16.2% YoY

WSFx Global Pay Ltd reported revenue from operations of ₹44.6 Cr (+30.0% YoY) and net profit of ₹4.3 Cr (+16.2% YoY) for Q2 FY27.

Key figure

Net profit ₹4.3 Cr · +16.2% YoY

Board Meeting Date

WSFx Global Pay Board Meeting Date

WSFx Global Pay Limited scheduled a Board meeting for October 26, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.